- Home
- PYPL vs IDXX Comparison
PYPL vs IDXX Comparison
Compare PYPL & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PYPL | IDXX |
|---|---|---|
| Founded | 1998 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.8B | 45.4B |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PYPL | IDXX |
|---|---|---|
| Price | $54.46 | $512.99 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 42 | 13 |
| Target Price | $56.92 | ★ $701.33 |
| AVG Volume (30 Days) | ★ 9.6M | 411.5K |
| Earning Date | 10-27-2026 | 11-02-2026 |
| Dividend Yield | ★ 1.03% | N/A |
| EPS Growth | ★ 35.59 | 22.59 |
| EPS | 1.21 | ★ 7.74 |
| Revenue | ★ $33,172,000,000.00 | $4,303,702,000.00 |
| Revenue This Year | $4.76 | $9.73 |
| Revenue Next Year | $4.20 | $8.86 |
| P/E Ratio | ★ $44.88 | $68.13 |
| Revenue Growth | 4.32 | ★ 10.42 |
| 52 Week Low | $38.46 | $500.61 |
| 52 Week High | $79.22 | $769.98 |
Technical Indicators
Market Signals| Indicator | PYPL | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 43.36 |
| Support Level | $51.51 | $500.61 |
| Resistance Level | $55.55 | $581.28 |
| Average True Range (ATR) | 1.42 | 12.39 |
| MACD | 0.25 | 1.95 |
| Stochastic Oscillator | 70.81 | 35.04 |
Price Performance
Historical ComparisonAbout PYPL PayPal Holdings Inc.
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 439 million active accounts at the end of 2025. The company also owns Venmo, a person-to-person payment platform.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.